FDA cautiously backs two abuse-deterrent opioids — 3 insights

  • Small
  • Medium
  • Large

The FDA approved Vantrela and Troxyca, two abuse-deterrent opioids, but also asked the medical community for better evaluations on abuse-deterrence, according to MedPage Today.

Here are three insights:

1. The Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety Risk Management Advisory Committee approved the two drugs.

2. The panel voted 14 to 3 on Vantrela, and 9 to 6 on Troxyca.

3. Vantrela is an abuse-deterrent formulation of extended-release hydrocodone. Troxyca is an abuse-deterrent formulation of extended-release oxycodone with naltrexone.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast